STOCK TITAN

Gilead EVP Wettan converts 590 RSUs, 285 withheld

Gilead’s EVP and general counsel had RSUs vest into common stock, with part of the shares withheld at $144.81 per share for tax or exercise obligations.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

GILEAD SCIENCES, INC. (GILD) reported that executive vice president and general counsel Keeley M. Cain Wettan had 590 restricted stock units convert into 590 shares of common stock on September 10, 2026. Of these shares, 285 were delivered or withheld at $144.81 per share to cover the exercise price or tax liability, and Cain Wettan continues to hold 13,405 restricted stock units directly. The units represent the right to receive common shares and follow a four-year vesting schedule with 25% vesting after one year and 6.25% vesting quarterly thereafter, and no Rule 10b5-1 trading plan is reported for these transactions.

Positive

  • None.

Negative

  • None.
Insider Cain Wettan Keeley M
Role EVP Gen Counsel, Legal & Comp
Type Security Shares Price Value
Exercise Restricted Stock Unit F1, F2 590 -- --
Exercise Common Stock F1 590 -- --
Exercise Price or Tax Liability Common Stock 285 $144.81 $41K
Holdings After Transaction: Restricted Stock Unit — 13,405 contracts (Direct); Common Stock — 8,759 shares (Direct)
Footnotes (2)
  1. F1. Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
  2. F2. The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.
Restricted stock units converted 590 units Units converted into common stock on September 10, 2026
Common shares withheld for exercise price or tax liability 285 shares Shares delivered or withheld on September 10, 2026
Per-share price for withheld shares $144.81 per share Price used for 285 shares delivered or withheld
Restricted stock units held after transaction 13,405 units Directly held by the executive after the September 10, 2026 transaction
Initial vesting portion 25% Portion of restricted stock units that vest on the first anniversary of the grant date
Subsequent quarterly vesting rate 6.25% quarterly Rate at which remaining restricted stock units vest until fully vested
Restricted Stock Unit financial
"Each restricted stock unit represents the contingent right to receive one share of"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
vesting schedule financial
"The restricted stock units have a 4-year vesting schedule. 25% vest on the first"
A vesting schedule is a timeline that determines when someone gains full ownership of certain benefits, such as company stock or retirement contributions. Think of it like earning the right to own a gift gradually over time, rather than receiving it all at once. It matters to investors because it affects when they can fully access or sell these benefits, influencing their financial planning and decision-making.
tax liability financial
"Payment of exercise price or tax liability by delivering or withholding securities"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did GILD disclose for Keeley M. Cain Wettan?

Gilead disclosed that Keeley M. Cain Wettan had 590 restricted stock units convert into 590 shares of common stock on September 10, 2026, with 285 shares delivered or withheld to cover the exercise price or tax liability.

How many GILD restricted stock units does the executive hold after the transaction?

After the September 10, 2026 transaction, Keeley M. Cain Wettan directly holds 13,405 restricted stock units, each representing the contingent right to receive one share of Gilead common stock, subject to the vesting schedule.

At what price were GILD shares withheld for taxes or exercise obligations?

A total of 285 shares of Gilead common stock were delivered or withheld at $144.81 per share in connection with the transaction, to satisfy the exercise price or related tax liability.

What is the vesting schedule for the GILD restricted stock units?

The restricted stock units have a four-year vesting schedule: 25% vest on the first anniversary of the grant date, and the remaining units vest at 6.25% quarterly thereafter until fully vested.

Was a Rule 10b5-1 trading plan used for this GILD insider transaction?

No. The filing indicates that no Rule 10b5-1 trading plan is reported for the transactions involving Keeley M. Cain Wettan on September 10, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cain Wettan Keeley M

(Last)(First)(Middle)
333 LAKESIDE DRIVE

(Street)
FOSTER CITY CALIFORNIA 94404

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
GILEAD SCIENCES, INC. [ GILD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP Gen Counsel, Legal & Comp
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/10/2026M590A(1)9,044D
Common Stock09/10/2026F285D$144.818,759D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit(1)09/10/2026M590 (2) (2)Common Stock590(1)13,405D
Explanation of Responses:
1. Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
2. The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.
Remarks:
/s/ Amy Kim by Power of Attorney for Keeley M. Cain Wettan09/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading